Exercise for Parkinson's (NCT06615115)
Improve walking and standing balance
- Trial ID
- NCT06615115
- Official Title
- Effects of an External and Combined Focus of Attention-Instructed Exercise Program on Postural Stability and Dual-Task Walking in Parkinson's Disease: A Randomized, Assessor-Blinded, Controlled Trial
- Goal
- Improve walking and standing balance
- Phase
- NA
- Status
- RECRUITING
- Sponsor
- Bahçeşehir University
- Study Type
- INTERVENTIONAL
- Enrollment
- 48 participants
- Conditions
- Parkinson Disease, Cognitive Deficit in Attention, Feedback, Psychological, Gait, Festinating
- Interventions
- Exercise
Summary For Families
Goal: To find out whether using a mix of two kinds of coaching during exercise can improve walking, balance, quality of life, and satisfaction for people with Parkinson's who do not have freezing episodes. Approach: Over six weeks participants exercise three times a week and are randomly assigned to receive combined internal and external focus instructions, external focus instructions alone, or standard exercise, with walking, balance, quality of life, and satisfaction measured before and after. Eligibility: About 48 people aged 50 to 70 with mild-to-moderate Parkinson's (stage II or III) who can walk independently but have balance problems, are in the period when their Parkinson's medication is working, meet basic cognitive screening, and do not have freezing of gait or major other medical or neurological conditions.
Locations
- Atafiz Tıp Merkezi, Istanbul, Turkey (Türkiye)
Frequently Asked Questions
- What is this trial testing?
- This trial is studying Exercise. Goal: To find out whether using a mix of two kinds of coaching during exercise can improve walking, balance, quality of life, and satisfaction for people with Parkinson's who do not have freezing episodes. Approach: Over six weeks participants exercise three times a week and are randomly assigned to receive combined internal and external focus instructions, external focus instructions alone, or standard exercise, with walking, balance, quality of life, and satisfaction measured before and after. Eligibility: About 48 people aged 50 to 70 with mild-to-moderate Parkinson's (stage II or III) who can walk independently but have balance problems, are in the period when their Parkinson's medication is working, meet basic cognitive screening, and do not have freezing of gait or major other medical or neurological conditions.
- Who can participate?
- Participants must be between 50 Years and 70 Years.
- Where is this trial located?
- This trial is recruiting at 1 location.
- Does it cost anything to join?
- You are never charged a fee to join a legitimate clinical trial, and the study treatment and study-specific tests are provided by the trial sponsor at no charge. In the US, routine care you would receive anyway can still be billed to you or your insurance; coverage rules differ by country, and trials in the UK and Canada usually run through public health systems. Travel, parking, and time are real costs, and some trials reimburse them while others do not. Before enrolling, ask the study coordinator to explain in writing what is and is not covered.
- How long does the trial last?
- This trial is estimated to last approximately 4 months.
- Can I leave the trial if I change my mind?
- Yes. You can withdraw from any clinical trial at any time, for any reason, without affecting your standard medical care. Trials are voluntary by law. The team may ask if you are willing to do a brief exit visit so they can collect safety information, but you are not obligated.
- Can my spouse or care partner come with me to visits?
- In most cases yes, and it is often encouraged. Care partners can help with notes, questions, and getting home safely after a long visit. Some study assessments do need to happen one on one, but care partners are usually welcome for the rest of the appointment.
- Will I get a placebo in this trial?
- There is no placebo group. Everyone receives an active treatment; the study compares one treatment against another.
- How many visits does this trial involve?
- Participants will attend an exercise program three days a week for six weeks.